Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
206.3 USD | -1.44% | -3.25% | +19.95% |
Financials (USD)
Sales 2024 * | 4.68B | Sales 2025 * | 5.03B | Capitalization | 30.31B |
---|---|---|---|---|---|
Net income 2024 * | 1.02B | Net income 2025 * | 1.23B | EV / Sales 2024 * | 6.61 x |
Net Debt 2024 * | 605M | Net cash position 2025 * | 366M | EV / Sales 2025 * | 5.95 x |
P/E ratio 2024 * |
29.7
x | P/E ratio 2025 * |
25.1
x | Employees | 10,140 |
Yield 2024 * |
0.95% | Yield 2025 * |
1.04% | Free-Float | 76.99% |
Latest transcript on ResMed, Inc.
1 day | -1.44% | ||
1 week | -3.25% | ||
1 month | -3.58% | ||
3 months | +18.77% | ||
6 months | +30.81% | ||
Current year | +19.95% |
Managers | Title | Age | Since |
---|---|---|---|
Mick Farrell
CEO | Chief Executive Officer | 51 | 00-08-31 |
Peter Farrell
FOU | Founder | 81 | 89-05-31 |
Brett Sandercock
DFI | Director of Finance/CFO | 57 | 97-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mick Farrell
CEO | Chief Executive Officer | 51 | 00-08-31 |
Ron Taylor
BRD | Director/Board Member | 76 | 04-12-31 |
Peter Farrell
FOU | Founder | 81 | 89-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.09% | 17 M€ | +6.09% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 206.3 | -1.44% | 2,928,056 |
24-05-30 | 209.3 | +1.64% | 602,077 |
24-05-29 | 206 | -0.58% | 599,076 |
24-05-28 | 207.2 | -2.86% | 829,545 |
24-05-24 | 213.3 | +0.79% | 536,176 |
Delayed Quote Nyse, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.95% | 30.31B | |
+7.01% | 217B | |
+11.01% | 190B | |
+19.20% | 143B | |
+30.79% | 111B | |
+1.48% | 64.59B | |
+13.95% | 52.36B | |
-0.16% | 48.45B | |
-6.20% | 38.03B | |
+0.91% | 35.61B |
- Stock Market
- Equities
- RMD Stock